Lido Advisors
CLLS

Lido Advisors’s Cellectis CLLS Stock Holding History

Lido Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32K Buy
+10,094
New +$38.7K ﹤0.01% 1916

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lido Advisors's CLLS Position: Q1 2026 in Review

Lido Advisors opened a new position in Cellectis (CLLS) in Q1 2026: 10,094 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1916 among its holdings.

32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Lido Advisors held 10,094 shares of Cellectis worth $32K as of Q1 2026.
  • Cellectis was a new Lido Advisors position in Q1 2026.
  • Cellectis made up ﹤0.01% of Lido Advisors's portfolio in Q1 2026, its #1916 holding.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.